脑病 GABRB 结构变异 共同的门和贩运缺陷
Ciria C Hernandez1, Ningning Hu2, Wangzhen Shen2
1Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA.
Biomolecules
|December 23, 2023
概括
GABRB基因中的遗传变异通过破坏GABA-A受体功能,导致性脑病. 了解突变如何影响受体结构和动态,可以预测疾病的严重程度.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 编码GABA-A受体β亚单元的GABRB基因变异与脑病变 (EEs) 和神经发育障碍有关.
- 这些疾病,包括德拉维特和安吉尔曼综合征,具有早期发作,发育问题和因GABA-A受体功能障碍而导致的认知障碍.
- 突变会破坏神经元激发和抑制的平衡,导致发作.
研究的目的:
- 调查13种与EE相关的GABRB误解变异对蛋白质稳定性,灵活性,通道功能和受体生物发生的影响.
- 为了将GABRB基因内的特定突变位置与观察到的功能和结构变化相关联.
- 建立一个框架,根据变异位置和对受体动态的影响来预测疾病严重程度.
主要方法:
- 对13个 de novo GABRB误解变体的分析.
- 评估蛋白质的稳定性和灵活性.
- 评估GABA-A受体通道功能和生物发生.
- 将变体映射到特定的功能域 (GABA-绑定,合区,孔隙域).
主要成果:
- 所有分析的GABRB变体都显著改变了蛋白质结构,稳定性,灵活性和功能.
- 关键领域 (GABA结合,合区,孔隙) 的突变影响了β+/α-接口,通道激活和受体贩运.
- 在研究的变种中,功能变化的程度各不相同.
结论:
- GABRB变体影响GABA-A受体的结构和功能,导致性脑病变.
- 受突变影响的特定结构域与受体功能障碍的程度相关.
- 评估变异位置和受体动态可以帮助预测GABRB相关疾病的疾病严重程度.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
412
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
412
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Rab Proteins
3.9K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
3.9K
Rab Cascades
2.7K
Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.
2.7K
Arteries of the Lower Limbs
191
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
191
Inborn Errors of Metabolism
162
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
162


